文献速递艾滋病与性传播感染

基于分子检测对阴道炎诊断留存样本进行性传播感染检测

Molecular-based Testing for Sexually Transmitted Infections Using Samples Previously Collected for Vaginitis Diagnosis.
PubMed 文献 · Clin Infect Dis · 2019-01-01

研究评估因阴道炎症状送检样本的女性中性传播感染(STI)的检出率,采用BD MAX CT/GC/TV检测沙眼衣原体、淋病奈瑟菌和阴道毛滴虫DNA。单纯细菌性阴道病或合并念珠菌感染的女性STI合并感染率高达24.4%-25.7%,阴道炎阴性者仅7.9%(P < .001)。BD MAX阴道panel与CT/GC/TV检测阴道毛滴虫在560份样本中559份一致。

要点

  • 有阴道炎症状的女性STI合并感染率可达24.4%-25.7%。
  • 阴道炎阴性女性STI阳性率为7.9%,显著低于有阴道炎者(P < .001)。
  • BD MAX阴道panel与CT/GC/TV检测阴道毛滴虫一致性高(559/560)。

核心结论

  • 数据显示,有阴道炎症状的女性可能存在STI风险,分子检测可为有症状女性提供广泛的诊断覆盖并改善患者管理,无论患者在何种诊所接受治疗。

研究设计与样本

  • 对因阴道炎送检样本的女性评估STI可能性,使用BD MAX CT/GC/TV检测计算沙眼衣原体、淋病奈瑟菌和阴道毛滴虫DNA阳性率。
  • 比较BD MAX阴道panel与BD MAX CT/GC/TV检测阴道毛滴虫的一致性。

主要发现

  • 单纯细菌性阴道病或合并念珠菌感染的女性STI合并感染率为24.4%-25.7%。
  • 阴道炎阴性女性样本STI阳性率为7.9%,显著低于有阴道炎者(P < .001)。
  • BD MAX阴道panel与BD MAX CT/GC/TV检测阴道毛滴虫在560份样本中559份一致。

临床怎么用

  • 原文结论提示,有阴道炎症状的女性可能存在STI风险,分子检测可提供广泛诊断覆盖并改善患者管理,无论诊所类型。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Vaginal symptoms are a leading cause of primary care visits for women. Individuals exhibiting symptoms often receive laboratory testing based on clinic-specific standards of care. Thus, women seen at a family practice clinic might only receive a vaginitis workup, whereas those seen at a sexually transmitted diseases clinic could be more likely to receive only sexually transmitted infection (STI) testing. METHODS: The likelihood of STIs was assessed in women from whom samples were tested for vaginitis using a molecular diagnostic assay. Positivity rates for Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis DNA, detected using the BD MAX CT/GC/TV assay, were calculated. Concordance between the BD MAX Vaginal Panel and the BD MAX CT/GC/TV assay for detection of T. vaginalis was determined. RESULTS: Women with bacterial vaginosis alone or with concurrent Candida spp infections had high rates of coinfection with sexually transmitted infections (24.4%-25.7%); samples from women who were negative for vaginitis had significantly lower positivity rates (7.9%; P < .001). Trichomonas vaginalis results were concordant between the BD MAX Vaginal Panel and the BD MAX CT/GC/TV assay in 559 of 560 samples tested. CONCLUSIONS: These data suggest, as have other studies, that women with vaginitis symptoms may be at risk for an STI. Molecular testing could provide broad diagnostic coverage for symptomatic women and improve patient management, regardless of the type of clinic in which patients are treated.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Van Der Pol B, Daniel G, Kodsi S, et al. Molecular-based Testing for Sexually Transmitted Infections Using Samples Previously Collected for Vaginitis Diagnosis. Clin Infect Dis. 2019. PMID: 30084883. doi:10.1093/cid/ciy504

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。